本页面由Tiger Trade Technology Pte. Ltd.提供服务

Syros Pharmaceuticals, Inc.

0.0002
0.0000
成交量:2,269.00
成交额:1.00
市值:5,366.49
市盈率:0.00
高:0.0008
开:0.0008
低:0.0002
收:0.0002
52周最高:0.2969
52周最低:0.0001
股本:2,683.25万
流通股本:2,391.73万
量比:0.03
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-3.0700
每股收益(LYR):-5.8100
净资产收益率:-776.96%
总资产收益率:-59.88%
市净率:-0.00
市盈率(LYR):0.00

数据加载中...

2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/05

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities